Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-07-29
2008-11-18
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S514000, C514S342000, C514S359000, C514S406000, C514S396000, C514S364000, C514S374000, C546S015000, C546S268700, C548S377100, C548S376100, C548S373100, C548S215000
Reexamination Certificate
active
07452899
ABSTRACT:
Compounds of Formula (I): inhibit the processing of APP by gamma-secretase, and hence are useful for treatment or prevention of Alzheimer's disease.
REFERENCES:
patent: 01/70677 (2001-09-01), None
patent: WO 01/70677 (2001-09-01), None
patent: WO 02/36555 (2002-05-01), None
patent: WO 03/093251 (2003-11-01), None
Dewachter et al., Lancet Neurology (2002), 1(7), 409-416.
Bettati Michela
Boase Amanda Louise
Churcher Ian
Ladduwahetty Tamara
Merchant Kevin John
Krovatin William
Merck Sharp & Dohme Limited
Rahmani Niloofar
Seaman D. Margaret
Yuro Raynard
LandOfFree
Gamma-secretase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gamma-secretase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gamma-secretase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4030351